Medipost Reports Positive Phase 3 Results for CARTISTEM in Japan’s Knee Osteoarthritis Trial_蜘蛛资讯网
reliability of the clinical outcomes. A notable aspect of the study design was the inclusion of two primary efficacy endpoints. These simultaneously assessed cartilage regeneration through arthroscop
g demographic characteristics between the two groups. The trial achieved a balanced distribution of key factors between the groups, including average patient age (61.3 years for CARTISTEM, 62.2 years